Therefore, shRNA 3 and shRNA 2 were then selected for MTT assay to validate the cell viability of drug-resistant cancer cells MCF-7/ADR and SMMC-7721/ADR after downregulating the expression of their intrinsic NDUFV2 gene and protein. This evidence concerns the gene NDUFV2 and cancer.